Architecting Sustainable Commercial Success
In the modern biopharmaceutical ecosystem, a clinical success is not a commercial guarantee. As articulated by industry thought leaders, the "Managed Markets" - including private payers, government health systems, and pharmacy benefit managers - are now the primary customers who define a product’s fate. At Livasyst, we recognize that "The Impact" is determined by how effectively a scientific truth claim is translated into a value-based narrative.
We specialize in identifying the elite commercial architects from Senior Sales Managers to Chief Commercial Officers - who possess the "systems thinking" required to navigate the high-stakes environment of market access, Sales, global pricing, and HEOR (Health Economics and Outcomes Research). Our approach is informed by the reality of "lifecycle compression," where the window to achieve peak sales has shrunk, necessitating leaders who can synchronize commercial strategy with R&D years before a launch.
Strategic oversight for 100+ specialized senior commercial and business mandates
Direct access to a vetted network of 1000+ MBAs and global commercial leaders
95%+ placement rate for high-stakes Market Access and Corporate Development roles.
Precision Leadership for Revenue Growth & Market Dominance
Visionary P&L owners responsible for global revenue execution, go-to-market architecture, and driving the transition from "Molecules to Markets."
Strategic architects who secure reimbursement and navigate complex payer environments, ensuring that "if there is no access, there is no script."
Leaders who drive inorganic growth through strategic investments, platform acquisitions, and managing the "meta-science" of pipeline backfilling.
The essential data storytellers who utilize outcomes research to substantiate a drug’s value beyond the limits of traditional clinical trials.
Operational architects who optimize field force sizing, territory alignment, and omnichannel engagement models to lift commercial productivity.
Senior strategists responsible for life-cycle management, indication expansion, and crafting compelling value propositions for both prescribers and patients.
A Methodology Informed by Commercial Reality and Scientific Rigor
We begin by analyzing your asset’s clinical differentiation and market access hurdles to define the exact leadership profile your launch requires.
Leveraging global networks, we identify and engage elite "A-player" leaders who are currently driving market share for competitors but are open to the right growth play.
A multi-dimensional assessment of a candidate’s ability to interact with R&D, Medical Affairs, and Regulatory teams to ensure commercial plans are scientifically grounded.
Evaluating "systems thinking"-the ability of a leader to anticipate the ripple effects of the Inflation Reduction Act (IRA) and geopolitical shifts on global pricing strategy.
Facilitating complex negotiations with deep intelligence on compensation, bonus structures, and equity incentives for high-demand commercial talent.
Executive integration support focused on aligning the new leader with your corporate mission and long-term pipeline milestones.
Our Unique Advantages in Business Recruitment
We understand the interdependencies between pricing, evidence generation, and commercial strategy, identifying leaders who can dismantle functional silos.
Livasyst excels at placing candidates who have firsthand experience managing relationships with PBM’s, national health systems (NHS, EMA), and institutional payers.
From AI-driven omnichannel engagement to digital therapeutics, we source leaders who understand how biology and technology intersect in the modern world market.
We prioritize cultural alignment and strategic fit, reducing the high cost of leadership turnover in an increasingly political and competitive environment.
Let’s discuss your leadership needs and how Livasyst can help you identify the commercial architects who will turn your scientific potential into sustainable market success.
Start Your Search